Clinical Trials
Clinical research used by the FDA to approve and monitor drugs, devices, and diagnostics must be well-designed and transparent.
Patients and clinicians deserve access to information on whether prescription drugs, medical devices, and diagnostics are safe and effective – and clinical trials are how we get this important data and evidence. Over time, there has been a decline in the quality of clinical trials used by the Food and Drug Administration (FDA) for approvals. This has led to use of drugs, devices, and diagnostics that have little benefit to patients and introduced greater confusion for providers and patients in deciding what medical products are best for them.
We aim to strengthen innovation through stronger FDA approval standards, greater clinical trial transparency, and accountability into the FDA’s reviews of clinical data, as well as assuring that insurance coverage reflects available clinical evidence. We advance these policy changes through research, policy development, technical assistance, advocacy, and education.
Resources
See allStories
See allMeet the Team
All PeopleNatilee Festa
Health Care Manager – Clinical Trials
Maggie Houle
Health Care Analyst - Drug Policy
Erin Jones
Health Care Manager- Drug Pricing
Mark E. Miller
Executive Vice President of Health Care
Andrea Noda
Vice President of Health Care – Drug Policy
Katherine Szarama
Director of Health Care – Clinical Trials (she/her)